GPC Biotech, Pharmion, Spectrum Pharmaceuticals, Yakult deal

GPC granted Yakult exclusive rights to develop and commercialize satraplatin in Japan. GPC will receive ¥1.2 billion ($9.7 million) up front and is eligible for undisclosed milestones, plus a minimum ...